Financhill
Sell
47

TFX Quote, Financials, Valuation and Earnings

Last price:
$121.91
Seasonality move :
2.49%
Day range:
$123.90 - $126.87
52-week range:
$118.70 - $249.91
Dividend yield:
1.08%
P/E ratio:
39.57x
P/S ratio:
1.95x
P/B ratio:
1.35x
Volume:
565K
Avg. volume:
539.4K
1-year change:
-39.43%
Market cap:
$5.5B
Revenue:
$3B
EPS (TTM):
$3.17

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
TFX
Teleflex
$699.4M $2.88 2.91% 98.97% $155.92
BDX
Becton Dickinson &
$5.4B $3.28 10.28% 104.06% $221.82
IART
Integra Lifesciences Holdings
$381.2M $0.43 -5.53% 241.78% $16.13
ISRG
Intuitive Surgical
$2.2B $1.73 16.8% 32.43% $575.49
LMAT
LeMaitre Vascular
$57.6M $0.50 11.88% 8.76% $104.50
PODD
Insulet
$543.3M $0.79 25.31% -64.13% $334.74
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
TFX
Teleflex
$125.44 $155.92 $5.5B 39.57x $0.34 1.08% 1.95x
BDX
Becton Dickinson &
$174.39 $221.82 $50B 33.28x $1.04 2.33% 2.42x
IART
Integra Lifesciences Holdings
$13.98 $16.13 $1.1B 70.14x $0.00 0% 0.66x
ISRG
Intuitive Surgical
$529.60 $575.49 $189.8B 77.65x $0.00 0% 22.06x
LMAT
LeMaitre Vascular
$83.63 $104.50 $1.9B 42.24x $0.20 0.86% 8.45x
PODD
Insulet
$298.73 $334.74 $21B 53.73x $0.00 0% 10.05x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
TFX
Teleflex
31.78% 0.357 30.89% 1.11x
BDX
Becton Dickinson &
43.29% -0.524 29.35% 0.48x
IART
Integra Lifesciences Holdings
54.74% 1.009 107.86% 0.57x
ISRG
Intuitive Surgical
-- 1.668 -- 3.81x
LMAT
LeMaitre Vascular
32.58% 1.475 8.86% 13.65x
PODD
Insulet
56.03% 2.516 9.18% 3.24x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
TFX
Teleflex
$389.4M $130.3M 2.43% 3.41% 18.2% $43.1M
BDX
Becton Dickinson &
$2.3B $637M 3.35% 5.86% 9.75% $35M
IART
Integra Lifesciences Holdings
$194.4M -$15.5M -0.86% -1.88% -2.93% -$40.2M
ISRG
Intuitive Surgical
$1.5B $578.1M 15.82% 15.82% 25.66% $465M
LMAT
LeMaitre Vascular
$41.4M $12.6M 11.41% 13.74% 25.94% $7.7M
PODD
Insulet
$409M $88.8M 15.79% 36.9% 10.07% $48.1M

Teleflex vs. Competitors

  • Which has Higher Returns TFX or BDX?

    Becton Dickinson & has a net margin of 13.56% compared to Teleflex's net margin of 5.84%. Teleflex's return on equity of 3.41% beat Becton Dickinson &'s return on equity of 5.86%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    BDX
    Becton Dickinson &
    42.81% $1.07 $44.5B
  • What do Analysts Say About TFX or BDX?

    Teleflex has a consensus price target of $155.92, signalling upside risk potential of 24.3%. On the other hand Becton Dickinson & has an analysts' consensus of $221.82 which suggests that it could grow by 27.2%. Given that Becton Dickinson & has higher upside potential than Teleflex, analysts believe Becton Dickinson & is more attractive than Teleflex.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    0 11 0
    BDX
    Becton Dickinson &
    4 11 0
  • Is TFX or BDX More Risky?

    Teleflex has a beta of 1.098, which suggesting that the stock is 9.761% more volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.251, suggesting its less volatile than the S&P 500 by 74.889%.

  • Which is a Better Dividend Stock TFX or BDX?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.08%. Becton Dickinson & offers a yield of 2.33% to investors and pays a quarterly dividend of $1.04 per share. Teleflex pays 91.2% of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or BDX?

    Teleflex quarterly revenues are $700.7M, which are smaller than Becton Dickinson & quarterly revenues of $5.3B. Teleflex's net income of $95M is lower than Becton Dickinson &'s net income of $308M. Notably, Teleflex's price-to-earnings ratio is 39.57x while Becton Dickinson &'s PE ratio is 33.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.95x versus 2.42x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.95x 39.57x $700.7M $95M
    BDX
    Becton Dickinson &
    2.42x 33.28x $5.3B $308M
  • Which has Higher Returns TFX or IART?

    Integra Lifesciences Holdings has a net margin of 13.56% compared to Teleflex's net margin of -6.61%. Teleflex's return on equity of 3.41% beat Integra Lifesciences Holdings's return on equity of -1.88%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    IART
    Integra Lifesciences Holdings
    50.81% -$0.33 $3.4B
  • What do Analysts Say About TFX or IART?

    Teleflex has a consensus price target of $155.92, signalling upside risk potential of 24.3%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $16.13 which suggests that it could grow by 15.34%. Given that Teleflex has higher upside potential than Integra Lifesciences Holdings, analysts believe Teleflex is more attractive than Integra Lifesciences Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    0 11 0
    IART
    Integra Lifesciences Holdings
    2 5 2
  • Is TFX or IART More Risky?

    Teleflex has a beta of 1.098, which suggesting that the stock is 9.761% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.164, suggesting its more volatile than the S&P 500 by 16.396%.

  • Which is a Better Dividend Stock TFX or IART?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.08%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or IART?

    Teleflex quarterly revenues are $700.7M, which are larger than Integra Lifesciences Holdings quarterly revenues of $382.7M. Teleflex's net income of $95M is higher than Integra Lifesciences Holdings's net income of -$25.3M. Notably, Teleflex's price-to-earnings ratio is 39.57x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.95x versus 0.66x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.95x 39.57x $700.7M $95M
    IART
    Integra Lifesciences Holdings
    0.66x 70.14x $382.7M -$25.3M
  • Which has Higher Returns TFX or ISRG?

    Intuitive Surgical has a net margin of 13.56% compared to Teleflex's net margin of 30.99%. Teleflex's return on equity of 3.41% beat Intuitive Surgical's return on equity of 15.82%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    ISRG
    Intuitive Surgical
    64.69% $1.92 $17.2B
  • What do Analysts Say About TFX or ISRG?

    Teleflex has a consensus price target of $155.92, signalling upside risk potential of 24.3%. On the other hand Intuitive Surgical has an analysts' consensus of $575.49 which suggests that it could grow by 8.67%. Given that Teleflex has higher upside potential than Intuitive Surgical, analysts believe Teleflex is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    0 11 0
    ISRG
    Intuitive Surgical
    14 9 1
  • Is TFX or ISRG More Risky?

    Teleflex has a beta of 1.098, which suggesting that the stock is 9.761% more volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.875%.

  • Which is a Better Dividend Stock TFX or ISRG?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.08%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or ISRG?

    Teleflex quarterly revenues are $700.7M, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. Teleflex's net income of $95M is lower than Intuitive Surgical's net income of $698.4M. Notably, Teleflex's price-to-earnings ratio is 39.57x while Intuitive Surgical's PE ratio is 77.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.95x versus 22.06x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.95x 39.57x $700.7M $95M
    ISRG
    Intuitive Surgical
    22.06x 77.65x $2.3B $698.4M
  • Which has Higher Returns TFX or LMAT?

    LeMaitre Vascular has a net margin of 13.56% compared to Teleflex's net margin of 18.39%. Teleflex's return on equity of 3.41% beat LeMaitre Vascular's return on equity of 13.74%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    LMAT
    LeMaitre Vascular
    69.18% $0.48 $515.6M
  • What do Analysts Say About TFX or LMAT?

    Teleflex has a consensus price target of $155.92, signalling upside risk potential of 24.3%. On the other hand LeMaitre Vascular has an analysts' consensus of $104.50 which suggests that it could grow by 24.96%. Given that LeMaitre Vascular has higher upside potential than Teleflex, analysts believe LeMaitre Vascular is more attractive than Teleflex.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    0 11 0
    LMAT
    LeMaitre Vascular
    3 6 0
  • Is TFX or LMAT More Risky?

    Teleflex has a beta of 1.098, which suggesting that the stock is 9.761% more volatile than S&P 500. In comparison LeMaitre Vascular has a beta of 0.827, suggesting its less volatile than the S&P 500 by 17.35%.

  • Which is a Better Dividend Stock TFX or LMAT?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.08%. LeMaitre Vascular offers a yield of 0.86% to investors and pays a quarterly dividend of $0.20 per share. Teleflex pays 91.2% of its earnings as a dividend. LeMaitre Vascular pays out 32.65% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or LMAT?

    Teleflex quarterly revenues are $700.7M, which are larger than LeMaitre Vascular quarterly revenues of $59.9M. Teleflex's net income of $95M is higher than LeMaitre Vascular's net income of $11M. Notably, Teleflex's price-to-earnings ratio is 39.57x while LeMaitre Vascular's PE ratio is 42.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.95x versus 8.45x for LeMaitre Vascular. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.95x 39.57x $700.7M $95M
    LMAT
    LeMaitre Vascular
    8.45x 42.24x $59.9M $11M
  • Which has Higher Returns TFX or PODD?

    Insulet has a net margin of 13.56% compared to Teleflex's net margin of 6.22%. Teleflex's return on equity of 3.41% beat Insulet's return on equity of 36.9%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    PODD
    Insulet
    71.88% $0.50 $3B
  • What do Analysts Say About TFX or PODD?

    Teleflex has a consensus price target of $155.92, signalling upside risk potential of 24.3%. On the other hand Insulet has an analysts' consensus of $334.74 which suggests that it could grow by 12.06%. Given that Teleflex has higher upside potential than Insulet, analysts believe Teleflex is more attractive than Insulet.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    0 11 0
    PODD
    Insulet
    14 2 0
  • Is TFX or PODD More Risky?

    Teleflex has a beta of 1.098, which suggesting that the stock is 9.761% more volatile than S&P 500. In comparison Insulet has a beta of 1.375, suggesting its more volatile than the S&P 500 by 37.475%.

  • Which is a Better Dividend Stock TFX or PODD?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.08%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or PODD?

    Teleflex quarterly revenues are $700.7M, which are larger than Insulet quarterly revenues of $569M. Teleflex's net income of $95M is higher than Insulet's net income of $35.4M. Notably, Teleflex's price-to-earnings ratio is 39.57x while Insulet's PE ratio is 53.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.95x versus 10.05x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.95x 39.57x $700.7M $95M
    PODD
    Insulet
    10.05x 53.73x $569M $35.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

How High Will Dollar General Stock Go?
How High Will Dollar General Stock Go?

Shares of Dollar General (NYSE:DG) have risen significantly in recent…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
75
INSM alert for Jun 11

Insmed [INSM] is up 7.75% over the past day.

Sell
25
AAON alert for Jun 11

AAON [AAON] is down 3.49% over the past day.

Buy
58
EXOD alert for Jun 11

Exodus Movement [EXOD] is down 8.21% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock